Stoddart, C.A.; Curreli, F.; Horrigan, S.; Altieri, A.; Kurkin, A.V.; Debnath, A.K.
Comparative Pharmacokinetics of a Dual Inhibitor of HIV-1, NBD-14189, in Rats and Dogs with a Proof-of-Concept Evaluation of Antiviral Potency in SCID-hu Mouse Model. Viruses 2022, 14, 2268.
https://doi.org/10.3390/v14102268
AMA Style
Stoddart CA, Curreli F, Horrigan S, Altieri A, Kurkin AV, Debnath AK.
Comparative Pharmacokinetics of a Dual Inhibitor of HIV-1, NBD-14189, in Rats and Dogs with a Proof-of-Concept Evaluation of Antiviral Potency in SCID-hu Mouse Model. Viruses. 2022; 14(10):2268.
https://doi.org/10.3390/v14102268
Chicago/Turabian Style
Stoddart, Cheryl A., Francesca Curreli, Stephen Horrigan, Andrea Altieri, Alexander V. Kurkin, and Asim K. Debnath.
2022. "Comparative Pharmacokinetics of a Dual Inhibitor of HIV-1, NBD-14189, in Rats and Dogs with a Proof-of-Concept Evaluation of Antiviral Potency in SCID-hu Mouse Model" Viruses 14, no. 10: 2268.
https://doi.org/10.3390/v14102268
APA Style
Stoddart, C. A., Curreli, F., Horrigan, S., Altieri, A., Kurkin, A. V., & Debnath, A. K.
(2022). Comparative Pharmacokinetics of a Dual Inhibitor of HIV-1, NBD-14189, in Rats and Dogs with a Proof-of-Concept Evaluation of Antiviral Potency in SCID-hu Mouse Model. Viruses, 14(10), 2268.
https://doi.org/10.3390/v14102268